Facilitation of brain stimulation reward by MK-801 (dizocilpine) may be independent of D2-like dopamine receptor stimulation in rats

Psychopharmacology

Volumn 182, Issue 1, 2005, Pages 65-74

  Clements, R L H ^a   Greenshaw, A J ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

7 OH DPAT; Apomorphine; Brain stimulation reward; Dopamine; Glutamate; MK 801; NMDA; Nucleus accumbens; Self stimulation; Ventral tegmental area

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; APOMORPHINE; DIZOCILPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; VENTRAL TEGMENTUM;

ANIMALS; APOMORPHINE; DIZOCILPINE MALEATE; DOMINANCE, CEREBRAL; DOPAMINE AGENTS; DRUG INTERACTIONS; MOTIVATION; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; REWARD; SELF STIMULATION; TETRAHYDRONAPHTHALENES; VENTRAL TEGMENTAL AREA;

EID: 25844472791     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0039-y     Document Type: Article

References (54)

1. Ahn KC, Pazderka-Robinson H, Clements RLH, Ashcroft R, Ali T, Morse C, Greenshaw AJ (2005) Differential effects of intra-midbrain raphe and systemic 8-OH-DPAT on VTA self-stimulation thresholds. Psychopharmacology (Berl) 178(4):381-388
2. 1 agonist elevates self-stimulation thresholds: comparison to other dopamine-selective drugs. Pharmacol Biochem Behav 62:659-672
3. 2/3 dopamine receptor stimulation in rats. Psychopharmacology (Berl) 179(1):189-197
4. Bubser M, Tzschentke T, Hauber W (1995) Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats. J Neural Transm Gen Sect 101:115-126
5. Burns LH, Everitt BJ, Kelley AE, Robbins TW (1994) Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement. Psychopharmacology (Berl) 115:516-528
6. Carlezon WA Jr, Wise RA (1993) Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res 620:339-342
7. Carlezon WA Jr, Wise RA (1996) Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward. Psychopharmacology (Berl) 128:413-420
8. 1 dopamine receptor stimulation increases GluR1 surface expression in nucleus accumbens neurons. J Neurochem 83:704-712
9. Choi KH, Zarandi B, Todd KG, Biondo AM, Greenshaw AJ (2000) Effects of AMPA/kainate receptor blockade on responses to dopamine receptor agonists in the core and shell of the rat nucleus accumbens. Psychopharmacology (Berl) 150:102-111
10. 2/3 receptor stimulation in the nucleus accumbens decreases brain stimulation reward in rats. Behav Brain Res 158:79-88
11. Corbett D (1989) Possible abuse potential of the NMDA antagonist MK-801. Behav Brain Res 34:239-246
12. Danysz W, Essmann U, Bresink I, Wilke R (1994) Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol Biochem Behav 48:111-118
13. 3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine. Psychopharmacology (Berl) 124:231-240
14. Depoortere R, Perrault G, Sanger DJ (1999) Intracranial self-stimulation under a progressive-ratio schedule in rats: effects of strength of stimulation, D-amphetamine, 7-OH-DPAT and haloperidol. Psychopharmacology (Berl) 142:221-229
15. 3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 20:8677-8684
16. Duncan GE, Zorn S, Lieberman JA (1999) Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia. Mol Psychiatry 4:418-428
17. Fiorino DF, Coury A, Fibiger HC, Phillips AG (1993) Electrical stimulation of reward sites in the ventral tegmental area increases dopamine transmission in the nucleus accumbens of the rat. Behav Brain Res 55:131-141
18. Fouriezos G, Francis S (1992) Apomorphine and electrical self-stimulation of rat brain. Behav Brain Res 52:73-80
19. Gallistel CR, Karras D (1984) Pimozide and amphetamine have opposing effects on the reward summation function. Pharmacol Biochem Behav 20:73-77
20. Garris PA, Kilpatrick M, Bunin MA, Michael D, Walker QD, Wightman RM (1999) Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation. Nature 398:67-69
21. 3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum. Brain Res 681:1-7
22. Greenshaw AJ (1997) A simple technique for determining stereotaxic coordinates for brain implantation of probes at rotated angles in one or two planes. J Neurosci Methods 78:169-172
23. Greenshaw AJ, Wishart TB (1987) Drug action and reward processes. In: Greenshaw AJ, Dourish CT (eds) Experimental psychopharmacology: concepts and methods. Humana Press, Totowa, pp 299-340
24. Gronier B, Debonnel G (1999) Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems. Eur J Pharmacol 368:183-196
25. 2 receptor agonists on intracranial self stimulation in the rat. Psychopharmacology (Berl) 140:405-410
26. Heidbreder C, Gewiss M, De Mot B, Mertens I, De Witte P (1992) Balance of glutamate and dopamine in the nucleus accumbens modulates self-stimulation behavior after injection of cholecystokinin and neurotensin in the rat brain. Peptides 13:441-449
27. Herberg LJ, Rose IC (1989) The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward. Psychopharmacology (Berl) 99:87-90
28. Imperato A, Tanda G, Frau R, Di Chiara G (1988) Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. J Pharmacol Exp Ther 245:257-264
29. Iversen SD (1995) Interactions between excitatory amino acids and dopamine systems in the forebrain: implications for schizophrenia and Parkinson's disease. Behav Pharmacol 6:478-491
30. Kaddis FG, Uretsky NJ, Wallace LJ (1995) DNQX in the nucleus accumbens inhibits cocaine-induced conditioned place preference. Brain Res 697:76-82
31. 3 preferring compounds on conditioned place preference and intracranial self-stimulation in the rat. J Neural Transm Gen Sect 101:27-39
32. Knapp CM, Kornetsky C (1996) Low-dose apomorphine attenuates morphine-induced enhancement of brain stimulation reward. Pharmacol Biochem Behav 55:87-91
33. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci U S A 89:8155-8159
34. Lewis RC, Elliott KAC (1950) Clinical uses of an artificial cerebrospinal fluid. J Neurosurg 7:256-260
35. Li Y, Vartanian AJ, White FJ, Xue CJ, Wolf ME (1997) Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology (Berl) 134:266-276
36. Ljungberg T, Ungerstedt U (1977) Different behavioural patterns induced by apomorphine: evidence that the method of administration determines the behavioural response to the drug. Eur J Pharmacol 46:41-50
37. Maldonado-Irizarry CS, Swanson CJ, Kelley AE (1995) Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J Neurosci 15:6779-6788
38. Olds ME (1996) Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801. Eur J Pharmacol 306:23-32
39. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic, Toronto, Canada
40. Pennartz CM, Groenewegen HJ, Lopes da Silva FH (1994) The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog Neurobiol 42:719-761
41. Phillips AG, Blaha CD, Fibiger HC (1989) Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses. Neurosci Biobehav Rev 13:99-104
42. 3 agonist PD 128907. J Pharmacol Exp Ther 275:1355-1366
43. Ranaldi R, Bauco P, Wise RA (1997) Synergistic effects of cocaine and dizocilpine (MK-801) on brain stimulation reward. Brain Res 760:231-237
44. 3H]TCP binding sites in guinea pig brain. In: Kamenka JM, Domino EF (eds) Multiple sigma and PCP receptor ligands. NPP Books, Ann Arbor, MI, pp 137-146
45. 3 receptors. Psychopharmacology (Berl) 130:387-395
46. 3 receptors and sigma sites in the bovine caudate nucleus. Eur J Pharmacol 242:R1-R2
47. Sesack SR, Pickel VM (1992) Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 320:145-160
48. Stephens DN, Cole BJ (1996) AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks. Psychopharmacology (Berl) 126:249-259
49. Strömbom U (1977) Antagonism by haloperidol of locomotor depression induced by small doses of apomorphine. J Neural Transm 40:191-194
50. 3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. J Neural Transm Gen Sect 95:71-74
51. Tzschentke TM, Schmidt WJ (1999) Memantine does not substantially affect brain stimulation reward: comparison with MK-801. Brain Res 845:192-198
52. Wan FJ, Swerdlow NR (1996) Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Res 722:168-176
53. 3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm (Gen Sect) 94:11-19
54. Wise RA (1996) Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19:319-340